Related Experiment Video
Updated: Apr 29, 2026

08:27
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.3K
Biomaterials for nanoparticle vaccine delivery systems
Preety Sahdev1, Lukasz J Ochyl, James J Moon
1Department of Pharmaceutical Sciences, College of Pharmacy University of Michigan, 2800 Plymouth Road NCRC, Ann Arbor, Michigan, 48109, USA.
Pharmaceutical Research
|May 23, 2014
Summary
Nanoparticle vaccine delivery enhances immune responses, overcoming subunit vaccine limitations. These advanced systems improve antigen delivery and immune cell targeting for potent, long-lasting immunity with reduced side effects.
Area of Science:
- Biotechnology
- Immunology
- Materials Science
Background:
- Subunit vaccines offer safety but struggle with weak, short-lived immune responses.
- Nanoparticle formulations can boost vaccine immunogenicity through material properties or adjuvant co-delivery.
Purpose of the Study:
- To review recent advances (last 5 years) in nanoparticle vaccine delivery systems.
- To highlight the influence of nanoparticle characteristics on immune responses.
Main Methods:
- Focus on nanoparticle composition, size, and surface charge.
- Analysis of nanoparticle impact on biodistribution, antigen/adjuvant delivery, and immune cell targeting.
- Review of various nanoparticle types: liposomes, micelles, polymers, and hybrid structures.
Main Results:
- Nanoparticles mimic pathogen cues to activate innate immunity.
- Tailored nanoparticle properties optimize antigen delivery and immune cell interaction.
- Nanoparticle systems demonstrate potential for enhanced systemic and mucosal immunity.
Conclusions:
- Nanoparticle vaccine delivery is a promising strategy to enhance immunogenicity and overcome subunit vaccine limitations.
- Careful design of nanoparticle biomaterials, size, and surface properties is crucial for effective immune modulation.
Related Concept Videos
Vaccine Production
136
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
136
Site-Targeted Drug Delivery Systems: Polymeric Carriers
159
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
159

